Biotech entity
All 1 tracked stories fall under one category: pharma. Anne Lockwood is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 4 original sources each. Genetic Signatures appears in 1 tracked Biotech story from February 26, 2026.
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Anne Lockwood is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 4 original sources each. Genetic Signatures appears in 1 tracked Biotech story from February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Genetic Signatures. Shared-story counts are live from our verified record — not editorial picks.
GSS Strategic Review
Board outlines steps to address unsustainable cash burn levels.
H1 FY26 Earnings Release
Genetic Signatures and ClearView Wealth report half-year results.
Zurich Acquisition Announced
ClearView Wealth enters Scheme Implementation Deed with Zurich.
Genetic Signatures (ASX:GSS) reported a modest revenue increase for H1 FY26 but warned that its current cash burn rate is unsustainable, prompting immediate board intervention. Meanwhile, the broader ASX landscape saw significant consolidation as ClearView Wealth (ASX:CVW) entered a definitive acquisition agreement with Zurich following a period of strong profitability.
Genetic Signatures is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
